Scientists have discovered how to turn used plastic bottles into a drug to treat Parkinson’s disease. Researchers at the University of Edinburgh genetically engineered bacteria ...

Researchers engineered a two-strain microbial system that converts PET-derived terephthalic acid into levodopa, overcoming key bottlenecks in transport and enzyme inhibition. The proof-of-concept ...

Scientists at University of Edinburgh engineered bacteria to convert plastic bottles into L-DOPA, a Parkinson's medication, ...

Immunis Inc. has struck a licensing deal with Japanese material manufacturer Toray Industries Inc. to develop a potential treatment for Parkinson’s-associated involuntary movement.

For the first time, researchers have developed a new method to transform common plastic ...

An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson's disease medication delivered through an infusion pump is safe and effective at reducing ...

News and commentary from the world of neurology and neuroscience ...

Treatment with Crexont statistically significantly improved “On” time without troublesome dyskinesia compared with carbidopa/levodopa IR. The Food and Drug Administration (FDA) has approved Crexont ® ...

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use adopted a positive opinion for Onerji (levodopa/carbidopa, Tanabe Pharma) for the treatment of adults with ...

Very long acting (> 6–8 h) levodopa preparations are still likely to represent the next chapter in the medical treatment of PD. Continuous-infusion levodopa gel, long-acting levodopa pills, ...

From standard medications to advanced drug delivery, surgery, and regenerative approaches, Parkinson's treatment options in ...